FDA Adverse Event Reports on Statin-Associated Rhabdomyolysis

@article{Omar2002FDAAE,
  title={FDA Adverse Event Reports on Statin-Associated Rhabdomyolysis},
  author={Mohamed Adel Omar and James P. Wilson},
  journal={Annals of Pharmacotherapy},
  year={2002},
  volume={36},
  pages={288 - 295}
}
  • Mohamed Adel Omar, James P. Wilson
  • Published 2002
  • Medicine
  • Annals of Pharmacotherapy
  • OBJECTIVE: To determine the number of cases of statin-associated rhabdomyolysis reported to the Food and Drug Administration for 6 statins and to profile the cases. METHODS: A retrospective analysis of all domestic and foreign reports of statin-associated rhabdomyolysis between November 1997 and March 2000 was conducted. Outcome measures included the total number of reports (initial plus follow-up), the number of unique cases, age, gender, percentages of report codes and role codes, and… CONTINUE READING

    Paper Mentions

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 223 CITATIONS, ESTIMATED 51% COVERAGE

    Ticagrelor Leads to Statin-Induced Rhabdomyolysis: A Case Report

    VIEW 1 EXCERPT
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    2002
    2020

    CITATION STATISTICS

    • 4 Highly Influenced Citations

    • Averaged 6 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 26 REFERENCES

    Statin—Fibrate Combination Therapy

    Interactions with hydroxymethylglutaryl-coenzyme A reductase inhibitors.

    • William R. Garnett
    • Medicine
    • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
    • 1995

    Drug interactions and the statins.

    • Robert J. Herman
    • Medicine
    • CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
    • 1999